Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Osterborg

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Blood|August 23, 2011
Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international studyWilliam G Wierda, Swaminathan Padmanabhan, Geoffrey W Chan, et al.
Blood|April 9, 2004
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasoneThomas Strömberg, Anna Dimberg, Anna Hammarberg, et al.
British Journal of Haematology|September 26, 2006
Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemiaMohammad Reza Rezvany, Mahmood Jeddi Tehrani, Claes Karlsson, et al.
British Journal of Haematology|January 14, 2004
Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stageFariba Mozaffari, Lotta Hansson, Shahryar Kiaii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patientsLotta Hansson, Amir Osman Abdalla, Ali Moshfegh, et al.
British Journal of Haematology|September 4, 2010
Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cellsAniruddha Choudhury, Katja Derkow, Amir Hossein Daneshmanesh, et al.
Experimental Hematology|April 4, 2013
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemiaMarzia Palma, Anton Parker, Mohammad Hojjat-Farsangi, et al.
Seminars in Cancer Biology|July 29, 2014
The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapyMohammad Hojjat-Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh, et al.
British Journal of Haematology|October 3, 2002
Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignanciesMichael Hedenus, Sören Hansen, Kerry Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemiaHeinz Ludwig, Jeffrey Crawford, Anders Osterborg, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Blood|August 23, 2011
Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international studyWilliam G Wierda, Swaminathan Padmanabhan, Geoffrey W Chan, et al.
Blood|April 9, 2004
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasoneThomas Strömberg, Anna Dimberg, Anna Hammarberg, et al.
British Journal of Haematology|September 26, 2006
Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemiaMohammad Reza Rezvany, Mahmood Jeddi Tehrani, Claes Karlsson, et al.
British Journal of Haematology|January 14, 2004
Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stageFariba Mozaffari, Lotta Hansson, Shahryar Kiaii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patientsLotta Hansson, Amir Osman Abdalla, Ali Moshfegh, et al.
British Journal of Haematology|September 4, 2010
Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cellsAniruddha Choudhury, Katja Derkow, Amir Hossein Daneshmanesh, et al.
Experimental Hematology|April 4, 2013
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemiaMarzia Palma, Anton Parker, Mohammad Hojjat-Farsangi, et al.
Seminars in Cancer Biology|July 29, 2014
The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapyMohammad Hojjat-Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh, et al.
British Journal of Haematology|October 3, 2002
Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignanciesMichael Hedenus, Sören Hansen, Kerry Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemiaHeinz Ludwig, Jeffrey Crawford, Anders Osterborg, et al.
Pageof 8